Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by DaveInCalgaryon Nov 05, 2023 1:27pm
142 Views
Post# 35718406

Tilray Brands - American Cannabis Update

Tilray Brands - American Cannabis UpdateAdvocacy Groups From Opposite Ends Of Political Spectrum Unite On Marijuana Push For Biden
November 2, 2023

Two advocacy coalitions reresenting opposite ends of the political spectrum have joined forces to call for President Joe Biden to remove marijuana from the federal Controlled Substances Act (CSA), saying it’s the only path that would fulfill the president’s campaign promises to decriminalize cannabis.

The two groups are the left-leaning Marijuana Justice Coalition and the more conservative Cannabis Freedom Alliance. The former includes members such as American Civil Liberties Union, Human Rights Watch, Center for American Progress, Leadership Conference on Civil & Human Rights and Drug Policy Alliance, while the latter is steered by organizations including the libertarian-minded Reason Foundation, Americans for Prosperity and R Street Institute.

In a joint letter to Biden sent on Thursday, the two coalitions note that together, they “represent a diverse range of non-profit and public interest groups.”

“We are writing with a unified voice,” they wrote, “to emphasize that only by descheduling marijuana from the Controlled Substances Act (CSA) can you fulfill your promise to the American people regarding cannabis decriminalization.”

While the Department of Health and Human Services (HHS) has recently recommended to the Drug Enforcement Administration (DEA) that marijuana be rescheduled from Schedule I to Schedule III of the CSA, the two coalitions say that change would fall short of Biden’s promised reform.

“Any action to move marijuana to another CSA schedule rather than removing it would simply maintain federal criminalization of these programs, licensed companies, and individuals operating in a fully legal manner under existing state rules and regulations,” the groups wrote. “Further, this mere change of scheduling classification as opposed to descheduling would not alleviate existing distrust in law enforcement around cannabis given the supermajority public support for ending criminalization.”

“For those reasons and more,” they continued, “we sincerely request that you oppose merely rescheduling cannabis under the CSA and instead urge you to deschedule the substance entirely.”

Removing marijuana completely from the CSA would allow state-based regulatory programs “to function as intended without unnecessary federal interference,” the letter says, although the groups also call on Biden to encourage Congress to craft “a well-thought-out plan for reasonable federal regulation and for implementing interstate commerce” as part of federal descheduling legislation.

“Now is the time to end federal marijuana criminalization, Mr. President,” the letter concludes, “not to rebrand it.”

Justin Strekal, founder of Better Organizing to Win Legalization and a member of the Marijuana Justice Coalition, said in a press release that “never before has ending marijuana criminalization enjoyed this level of organized cross-ideological support.”

“It is critical for the president and his administration to recognize that now is the time for them to seize the moment and deliver a win for the American People in the form of a rational and just cannabis policy future,” he said. “At this point, not doing so, should be considered political malpractice.”

(Disclosure: Strekal supports Marijuana Moment’s work via a monthly Patreon pledge.)

The advocates’ letter comes on the heels of a separate effort by 31 bipartisan House members who last month urged DEA to consider descheduling marijuana completely rather than moving the substance to Schedule III. They also called on the agency to consider current state and congressional legalization efforts as it carries out its review of the HHS recommendation.

That letter, sent to DEA Administrator Anne Milgram and led by Congressional Cannabis Caucus co-chairs Reps. Earl Blumenauer (D-OR), Dave Joyce (D-OR), Barbara Lee (D-CA) and Brian Mast (R-FL), said that “the administration and relevant agencies such as yours should recognize the merits of full descheduling and work with congressional leaders to ensure this happens,” adding that prohibition “does not reflect the will of the broader American electorate” and “it is time that [DEA’s] work fully reflects this reality as well.”

Lawmakers pointed out that the vast majority of states have enacted some form of legalization, and members from both sides of the aisle have introduced legislation to follow suit at the federal level. The House has twice passed comprehensive legalization legislation, they noted.

While moving marijuana to Schedule III would “start to remedy this disconnect” between federal and state policies, they said it would not go far enough for “marijuana businesses, patients, and consumers.”

Other signatories of the letter Reps. Jack Bergman (R-MI), Bonnie Watson Coleman (D-NJ), Lou Correa (D-CA), Pramila Jayapal (D-WA), James McGovern (D-MA), Jerrold Nadler (D-NY), Eleanor Holmes Norton (D-DC), Dean Phillips (D-MN), Katie Porter (D-CA), David Trone (D-MD) and others.

The letter serves as a counterbalance to other recent messages DEA has received from congressional opponents of reform and former DEA and White House drug czars who argue that even moving marijuana to Schedule III would go too far.

A coalition of 14 Republican congressional lawmakers recently urged DEA to “reject” the top federal health agency’s recommendation to reschedule marijuana and instead keep it in the most restrictive category under the CSA.

Meanwhile, two GOP senators, including the lead Republican sponsor of a marijuana banking bill that cleared a key committee last month, recently filed new legislation to prevent federal agencies from rescheduling cannabis without tacit approval from Congress.

Advocates and lawmakers who support cannabis reform, meanwhile, marked the one-year anniversary of Biden’s mass marijuana pardon and scheduling directive by calling on him to do more—including by expanding the scope of relief that his pardon had and by expressly supporting federal legalization.
Late last month, HHS released a highly redacted version of a brief letter to DEA’s Milgram regarding the agency’s marijuana rescheduling recommendation. The letter confirmed certain previously reported details, such as the date of the correspondence, August 29, and the author, HHS Assistant Secretary for Health Rachel Levine. But it was redacted to exclude the substance of the message, including both the scheduling recommendation itself and a scientific review that was attached to the letter.


Read the organizations’ full marijuana letter to Biden below:

November 2nd, 2023
The White House
1600 Pennsylvania Avenue,
N.W. Washington, DC 20500

Dear President Biden,
We are writing to express our gratitude for your willingness to acknowledge the failure of marijuana prohibition and your commitment to decriminalize the substance. As leading coalitions working closely with both sides of the aisle in Congress to find a legislative solution, the Marijuana Justice Coalition and the Cannabis Freedom Alliance represent a diverse range of non-profit and public interest groups. We are writing with a unified voice to emphasize that only by descheduling marijuana from the Controlled Substances Act (CSA) can you fulfill your promise to the American people regarding cannabis decriminalization. According to the most recent FBI data, nearly 250,000 individuals were arrested for marijuana- related charges nationwide in 2021. People arrested for marijuana often face severe penalties, including months of prison or jail time and thousands of dollars in fines. Incarceration or an arrest creates barriers to securing gainful employment, education, and housing opportunities. While people of all races tend to use marijuana at the same rate, Black individuals are arrested three times more often than their white counterparts for the same offense. Currently, the cannabis marketplace is regulated by 48 states through various regulatory systems. In our federal system, these laboratories of democracy should not be impeded in their development of effective measures to ensure public safety and promote public health. Any action to move marijuana to another CSA schedule rather than removing it would simply maintain federal criminalization of these programs, licensed companies, and individuals operating in a fully legal manner under existing state rules and regulations. Further, this mere change of scheduling classification as opposed to descheduling would not alleviate existing distrust in law enforcement around cannabis given the supermajority public support for ending criminalization. For those reasons and more, we sincerely request that you oppose merely rescheduling cannabis under the CSA and instead urge you to deschedule the substance entirely, allowing state-based regulatory programs to function as intended without unnecessary federal interference. We further urge you to use your influence to encourage Congress to pass comprehensive marijuana descheduling legislation that includes a well-thought-out plan for reasonable federal regulation and for implementing interstate commerce that protects public health and the ability for small businesses to thrive in the emerging legal marketplace. Now is the time to end federal marijuana criminalization, Mr. President, not to rebrand it.

Sincerely,
The Marijuana Justice Coalition and Cannabis Freedom Alliance

https://www.marijuanamoment.net/advocacy-groups-from-opposite-ends-of-political-spectrum-unite-on-marijuana-push-for-biden/

<< Previous
Bullboard Posts
Next >>